Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$IFBC Key Investment Factors #IFBC
Growing – Dino Luzzi grew revenues from $38,137 in 2021 to $128,430 in 2022. That’s a 238% increase YoY. This shows the product is in demand, and that demand is growing.
Taste – Dino Luzzi beats out the big guys in blind taste tests. That’s no small feat. While brand recognition remains strong
Expansion Plans – IFBC has developed a significant prime retail space in Western Beef, a New-York based grocer. With 22 warehouse style stores and locations across the Northeastern US (and a few Florida outlets), Dino Luzzi has plenty of shelves to grow into. Additionally, the company has recently partnered with Key Food Fresh and Iavarone Bros. https://microcaps.com/a-ground-floor-opportunity-in-a-growing-energy-drink-company/
$TWOH TWO HANDS GROUP: WEATHERING THE STORM AND POISED FOR A TURNAROUND https://twohandsgroup.com/blog/twoh-weathering-the-storm
FRC has given $MLRT - MetAlert a "Buy" recommendation with a fair value estimate of $0.14 per share! Get in before it explodes!
https://www.linkedin.com/posts/metalertinc_metalertinnovation-futureofsafety-smartinvesting-activity-7176535618619891712-m-PZ
$NBIO - Once successfully commercialized, the Company hopes to eliminate bi-weekly weekly infusions, allowing patients to administer Pritumumab and avoid inconvenient, tedious, and uncomfortable multi hour cancer center treatment visits.
https://finance.yahoo.com/news/nascent-collaborates-hypospray-pharma-proprietary-120000958.html
$GVH News: Globavend Holdings Limited Enters Into a US$20,000,000 Equity Line of Credit Facility to be Registered on Form F-1
PERTH, AUSTRALIA, March 18, 2024 (GLOBE NEWSWIRE) -- Globavend Holdings Limited (Nasdaq: GVH) (the “Company” or “Globavend”), an emerging e-commerce logistics provider, is pleased to announce that it has entered into a US$20,000,000 equity purchase agreement (the “Equity Purchase Agreement”) with Square Gate Capital Master Fund, LLC – Series 1 (“Square Gate”), as well as a registration rights agreement (“Registration Right Agreement”) related thereto. Pursuant to the terms of the Registration Rights Agreement, the Company will register the Company’s ordinary shares (the “Shares”) issuable to Square Gate under the Equity Purchase Agreement for public resale.
Globavend will have the right, but not the obligation, to sell to Square Gate up to US$20,000,000 worth of its Shares at Globavend’s sole discretion over the next 36 months, subject to certain conditions precedent and other limitations. Square Gate will have the obligation to purchase the Shares a price determined in accordance with certain formulas set forth in the Equity Purchase Agreement and subject to certain dollar caps.
Wai Yiu Yau, CEO of Globavend stated “This equity line facility provides Globavend with a viable long-term platform to grow its existing operations, expand its e-commerce logistics services into different verticals of the logistics supply chain, enhance its business presence in Australia, New Zealand and Hong Kong, and capitalize on other potential business opportunities. We are always mindful of the best interests of our shareholders and are committed to deliver solid financial performance for the company in 2024 and beyond.”
About Globavend Holdings Limited
Globavend Holdings Limited is an emerging e-commerce logistics provider offering end-to-end logistics solution in Hong Kong, Australia and New Zealand. The Company’s customers are primarily enterprise customers, being e-commerce merchants, or operators of e-commerce platforms, in providing business-to-consumer (B2C) transactions. As an e-commerce logistics provider, the Company provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution, from pre-carriage parcel drop off to parcel consolidation, air-freight forwarding, customs clearance, on-carriage parcel transportation and delivery.
Forward-Looking Statements
This press release contains certain forward-looking statements, including statements with regard to the Company’s proposed transaction and the future potential of the Company. Words such as “will,” future,” “expects,” “believes,” and “intends,” or similar expressions, are intended to identify forward-looking statements. Forward-looking statements are subject to inherent uncertainties in predicting future results and conditions and no assurance can be given that the proposed transaction discussed above will be completed on the terms described or achieve the objectives contemplated. Our ability to utilize the financing platform effectively and successfully are subject to numerous factors, many of which are beyond the control of the Company, including, without limitation, the failure of customary conditions precedent and the risk factors and other matters set forth in our annual report on Form 20-F. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.
For investor and media inquiries, please contact:
Company Info:
Globavend Holdings Limited
Wai Yiu Yau, Chairman and CEO
project@globavend.com 61 08 6141 3263
https://www.globenewswire.com/newsroom/ti?nf=OTA2NDkzNiM2MTQwMDkzIzUwMDExOTk3MQ==
https://ml.globenewswire.com/media/MjM0ZWI4MTEtYjI1Zi00ZTg5LTgzZDktOGQ3YjYzMDNmNWFmLTUwMDExOTk3MQ==/tiny/Globavend-Holdings-Limited.png
Source: Globavend Holdings Limited
The Company has selected Rangefront Geological ("Rangefront") to perform both a detailed soil sampling on a 250 m X 250 m spacing and to oversee a CSAMT geophysical survey performed by KLM Geoscience.
$EVKRF
$EVKRF News: Grid Battery To Begin the 2024 Exploration Program on Its Clayton Valley Lithium Project
March 13, 2024
Link to news with images:
https://marketwirenews.com/news-releases/grid-battery-to-begin-the-2024-exploration-program-o-8421939950779981.html
$IQST- iQSTEL could be the next big thing in the stock market.
$VTAK Catheter Precision, Inc. (NYSE American: VTAK) Announces the First use of LockeT Outside of the United States
https://www.accesswire.com/841419/catheter-precision-inc-nyse-american-vtak-announces-the-first-use-of-locket-outside-of-the-united-states
$INBS Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
https://www.globenewswire.com/news-release/2024/03/11/2843777/0/en/Intelligent-Bio-Solutions-Announces-10-1-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html
$GDHG - Golden Heaven's five amusement parks collectively had approximately 100,362 guest visits. This figure represents an approximately 28.4% increase in park attendance over the corresponding period in 2023
$TMGI - Marc Angell, CEO of The Marquie Group further commented, “This reduction is expected to enhance shareholder confidence considerably.”
https://finance.yahoo.com/news/marquie-group-lowers-authorized-shares-145500286.html
$SYNX Silynx headset systems protect against impulse and steady-state noises while enabling the user to hear ambient noises, via “hear-thru” functionality, and maintain 360° situational awareness. https://www.silynxcom.com/military/
$LBRG With the wholly owned subsidiary, Growhouse Nutraceuticals, poised for significant topline growth in 2024, the Company anticipates reaching a projected revenue of $25,000,000 for the calendar year.
https://finance.yahoo.com/news/ladybug-group-inc-rebrands-ladybug-121500618.html
In an era where digital innovation is not just an advantage but a necessity, $CBDW 1606 Corp emerges as a visionary leader, redefining the landscape of customer and investor engagement through advanced AI-driven chatbots. https://cbdw.ai/chatbot-technology-by-1606-corp-paves-the-way-for-increased-value-profitability/
BriaCell will be presenting three posters at the 2024 American Association for Cancer Research ( @glenp at San Diego Convention Center, San Diego, CA. For additional information, please visit: https://bit.ly/433oQnS #AACR24 $BCTX $BCTXW
$CETX News: Cemtrex Announces Beta Release of Pioneering AI Gun Detection Feature
Disruptive Artificial Intelligence (AI) Gun Detection Feature to Launch in the Second Calendar Quarter of 2024, Marking a Significant Milestone Achievement for Detecting Armed Persons in Surveillance Footage
Hauppauge, NY, March 06, 2024 (GLOBE NEWSWIRE) -- - Cemtrex Inc. (NASDAQ: CETX, CETXP), an advanced security technology and industrial services company, today announced that its subsidiary, Vicon, is expected to commence the beta release of its innovative Artificial Intelligence (AI) gun detection feature in the second calendar quarter of 2024, marking a significant milestone in public safety and security technology. This groundbreaking feature is designed to function on edge devices, offering a low-cost, high-efficiency solution for detecting armed persons in surveillance footage and enhancing the capabilities of video management systems to initiate specific responses upon detection.
The introduction of this AI feature, with full commercialization planned for the second half of 2024, is part of Vicon’s commitment to developing cutting-edge solutions that meet the dynamic needs of our customers. This commercialization strategy allows for gathering real-world insights and refining the technology based on feedback from live environments, ensuring the delivery of a superior product experience. Current solutions on the market are generally server-based which are extremely cost prohibitive and difficult to deploy, whereas Vicon’s approach for an edge-based solution, offers a more effective alternative.
Vicon, in collaboration with its technology partners, is developing this feature to provide real-time alerts and facilitate rapid response, thereby playing a crucial role in enhancing security measures and potentially preventing violent incidents before they occur. The value of integrating gun detection technology into video surveillance systems offers significant advancements in the ability of organizations to protect their premises and the people within them, providing peace of mind in increasingly uncertain times.
"Our goal is not only to innovate but to make a meaningful contribution to public safety," said Saagar Govil, CEO of Cemtrex. "The early adoption and feedback through our beta release are vital in shaping a solution that truly meets societal needs. By making advanced gun detection technology accessible and affordable, we aim to equip organizations with the tools they need to enhance their security protocols and respond more effectively to potential threats."
Gun violence remains a pressing issue in the United States, with provisional data for 2022 from the Centers for Disease Control and Prevention highlighting the urgent need for innovative solutions:
Over 48,000 firearm-related deaths, including nearly 20,000 homicides, were recorded in the U.S.
An average, 132 Americans died from a firearm-related injury each day, with hundreds more shot and injured.
Guns remained the leading cause of death for children and teens, climbing 87% in the last decade.
Recent years have seen a stark increase in school shootings, with 2021, 2022 and 2023 all setting records since at least 2008. There were at least 82 incidents in 2023, but 2022 was one of the deadliest years, with 46 fatalities, according to CNN.
Vicon's AI gun detection technology aims to contribute significantly to efforts to reduce gun violence and its devastating impact on communities across the nation. The Company sees the market opportunity for this feature to be vast, ranging from schools, hospitals, government buildings, retail, to religious institutions.
About Cemtrex
Cemtrex Inc. (CETX) is a company that owns two operating subsidiaries: Vicon Industries Inc and Advanced Industrial Services Inc.
Vicon Industries, a subsidiary of Cemtrex Inc., is a global leader in advanced security and surveillance technology to safeguard businesses, schools, municipalities, hospitals and cities. Since 1967, Vicon delivers mission-critical security surveillance systems, specializing in engineering complete security solutions that simplify deployment, operation and ongoing maintenance. Vicon provides security solutions for some of the largest municipalities and businesses in the U.S. and around the world, offering a wide range of cutting-edge and compliant security technologies, from AI-driven video analytics to fully integrated access control solutions. For more information visit www.vicon-security.com
AIS – Advanced Industrial Services, a subsidiary of Cemtrex, Inc., is a premier provider of industrial contracting services including millwrighting, rigging, piping, electrical, welding. AIS Installs high precision equipment in a wide variety of industrial markets including automotive, printing & graphics, industrial automation, packaging, and chemicals. AIS owns and operates a modern fleet of custom designed specialty equipment to assure safe and quick installation of your production equipment. Our talented staff participates in recurring instructional training, provided to ensure that the most current industry methods are being utilized to provide an efficient and safe working environment. For more information visit www.ais-york.com
For more information visit www.cemtrex.com.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the closing of the offering, gross proceeds from the offering, our new product offerings, expected use of proceeds, or any proposed fundraising activities. These forward-looking statements are based on management’s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by such forward looking statements. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. These risks and uncertainties are discussed under the heading “Risk Factors” contained in our Form 10-K filed with the Securities and Exchange Commission. All information in this press release is as of the date of the release and we undertake no duty to update this information unless required by law.
https://www.globenewswire.com/newsroom/ti?nf=OTA1OTAyMiM2MTIzNTA1IzIwNDk3MDg=
https://ml.globenewswire.com/media/YmFhNDM0Y2ItNmNiNS00MmQ5LThkNDgtNGYyMDA2ZDBlNWU4LTEwNjEyNzk=/tiny/Cemtrex-Inc-.png
Investor Relations
Chris Tyson
Executive Vice President – MZ North America
Direct: 949-491-8235
CETX@mzgroup.us
www.mzgroup.us
Source: Cemtrex Inc.
$MSRM Mushrooms Inc. (OTC:MSRM) Launches New Health Supplements, Progresses with German Partnership, and Boosts Engagement Initiatives
https://www.globenewswire.com/news-release/2024/03/05/2840578/0/en/Mushrooms-Inc-OTC-MSRM-Launches-New-Health-Supplements-Progresses-with-German-Partnership-and-Boosts-Engagement-Initiatives.html
$ARTM - Our excellent android version of NewborhoodTalks has also been recently updated and can be found in the Google Play Store.
https://finance.yahoo.com/news/american-nortel-communications-inc-announces-133000601.html
$DTMXF AI Power Hour looms closer...
Content Optimization
Utilize AnalyticsGPT to tap into authentic conversations. Focus content creation on real audience interests and trends, delivering content that drives traffic and enhances customer engagement.
https://www.datametrex.com/analyticsgpt
$LBRG Ladybug Announces Acquisition of E-Commerce Generating $2.4 Million Annual Revenue
https://www.globenewswire.com/news-release/2024/03/05/2840311/0/en/Ladybug-Announces-Acquisition-of-E-Commerce-Generating-2-4-Million-Annual-Revenue.html
$SYNX Silynxcom Receives $400,000 Follow Up Order from a Leading Global Defense Company
https://finance.yahoo.com/news/silynxcom-receives-400-000-order-140000351.html
Ladybug $LBRG Announces Acquisition of E-Commerce Generating $2.4 Million Annual Revenue https://www.reddit.com/r/10xPennyStocks/comments/1b7923j/ladybug_lbrg_announces_acquisition_of_ecommerce/
$DFCO's CEO talks big new contracts in new interview! Who knew the heat pump market was so big in Europe and that is only part of what Dalrada does? They have multiple revenue streams and on track for cash flow positive this year!
Eyes on $DTMXF the next AI play starting...
Volume Alert and UP 75%.
Lots of good news has flowed, and a low floater.
$NRXP News: NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, Last Visit in its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
Marks a major step in the development of what could be the first drug approved for Suicidal Bipolar Depression
The study database is being cleaned and locked; statistical analysis and top-line data to follow shortly thereafter
Study maintained 95% concordance rate between study sites and central raters on primary endpoint. No unexpected Serious Adverse Events were reported.
Positive data and FDA comment would trigger the next $4 million milestone payment from partners Alvogen and Lotus and their assumption of development costs; agreement provides for up to $329 million in milestone payments and a royalty on Net Sales in the mid-teens
RADNOR, Pa., March 4, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that the 74th and last evaluable patient has completed their day 42 visit in its Phase 2b/3 study of NRX-101, the Company's patented combination of the NMDA antagonist D-cycloserine and lurasidone, in Suicidal Treatment Resistant Bipolar Depression. The database is being cleaned, finalized, and locked; statistical analysis will then be performed, with top-line data to follow shortly thereafter. As previously disclosed, positive data from this trial triggers a milestone payment from Alvogen. Alvogen will then be responsible for further development and commercialization costs for this program.
NRX-101 has been awarded Breakthrough Therapy Designation, Fast Track Designation, a Biomarker Letter of Support, and a Special Protocol Agreement by the FDA for treatment of suicidal bipolar depression. It is the only oral medication to have demonstrated reduced suicidal ideation in patients with bipolar depression, a lethal disease that claims the lives of one in five who live with it.
"This is the first clinical trial, to the company's knowledge, conducted among patients with suicidal bipolar depression in the outpatient setting. Our previous trial measured the ability of NRX-101 to maintain the anti-depressant and anti-suicidal effect of ketamine administered in the hospital setting. These patients, whose clinical need is urgent and extraordinary have routinely been excluded from the clinical trials of all previously-known anti-depressant drugs. said Dr. Jonathan Javitt, Founder, Chairman and Chief Scientist of NRx Pharmaceuticals. Although there were patients whose depression worsened and required hospitalization (we don't yet know whether they were on NRX-101 or comparator), patient safety was maintained, and no trial participant suffered a serious unexpected adverse outcome. Our thanks go out to our investigators, clinics, partners and, most importantly, our amazing patients and their families for seeing this study through to this important milestone," "
The Phase 2b/3 trial (www.clinicaltrials.gov NCT 03395392) is a randomized, prospective, multicenter, double-blind study comparing NRX-101 to lurasidone over six weeks. The Principal Investigator is Prof. Andrew Nierenberg of Harvard Massachusetts General Hospital. The primary efficacy endpoint is reduction in depression as measured on the MADRS scale and the secondary endpoint is reduction of suicidal ideation as measured by the Clinical Global Impression Suicidality Scale (CGI-SS). As previously disclosed, treatment compliance and concordance of local raters to central raters scores was in excess of 94%, well above the industry standard that is normally seen in CNS trials.
Top-line results are expected around the end of this quarter.
About NRx Pharmaceuticals
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx has partnered with Alvogen and Lotus around the development and marketing of NRX-101 for the treatment of suicidal bipolar depression. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.
NRx has recently announced plans to submit a New Drug Application for HTX-100 (IV ketamine), through Hope Therapeutics, in the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.
About HOPE Therapeutics, Inc.
HOPE Therapeutics, Inc. (www.hopetherapeutics.com) is a Specialty Pharmaceutical Company, wholly-owned by NRX Pharmaceuticals focused on development and marketing of an FDA-approved form of intravenous ketamine for the treatment of acute suicidality and depression together with a digital therapeutic-enabled platform designed to augment and preserve the clinical benefit of NMDA-targeted drug therapy.
Notice Regarding Forward-Looking Statements
The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, among others, statements regarding the proposed public offering and the timing and the use of the proceeds from the offering. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. Except as may be required by applicable law, The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise.
https://c212.net/c/img/favicon.png?sn=CL51263&sd=2024-03-04 View original content to download multimedia:https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaq-nrxp-announces-last-patient-last-visit-in-its-phase-2b3-trial-of-nrx-101-in-suicidal-treatment-resistant-bipolar-depression-302078041.html
SOURCE NRx Pharmaceuticals, Inc.
$CYIO - With the new caboncred.io launched, CYIOS leadership will continue working closely with digital marketing partner, INTENT SCIENCES with thorough GTM strategies in order to build brand awareness and to help grow the business online via SEO, social media, PR and media coverage over the next several months.
https://finance.yahoo.com/news/cyios-corp-shareholder-carboncred-carbon-150000460.html
$TWOH -- NAVIGATING THE FUTURE: THE EVOLUTION OF MICRO MERCHANT FOOD WHOLESALERS https://twohandsgroup.com/blog/micro-merchant-wholesalers-evolution
$SYNX is proud to announce that it has developed an innovative new product designed for dogs in militaries. The cutting-edge headset, having been the subject of the Company’s extensive research and engineered based on the Company’s expertise in communication technology, is designed to offer robust protection for and to enable seamless command transmission via radio directly to military dogs.https://www.nasdaq.com/press-release/silynxcom-unveils-groundbreaking-headset-for-military-dogs-offering-unparalleled
$GDHG News: Golden Heaven Group Holdings Ltd. to Expand into Indonesia Market with its Strategic Partnership
February 29, 2024
News Link:
https://www.prnewswire.com/news-releases/golden-heaven-group-holdings-ltd-to-expand-into-indonesia-market-with-its-strategic-partnership-302074850.html
$EVKRF - Four drillholes are recommended for a Phase 1 Reverse Circulation program at the Texas Spring Property, targeting the mineralized zones identified in surface sampling.
https://finance.yahoo.com/news/grid-battery-metals-team-provides-123000945.html
$AGBA - Trusted by over 400,000 individual and corporate customers, the Group focuses on four market-leading businesses:
Platform Business, Distribution Business, Healthcare Business & FinTech Business.
https://www.agba.com/
$IVDN: Insultex House Wrap® with its unmatched R-6 rating, meets or exceeds new building codes going into effect across the US which require continuous insulation for higher thermal performance standards. Learn more at: http://insultexhousewrap.com #ContinuousInsulation #HomeBuilding
$IVDN: Insultex House Wrap® with its unmatched R-6 rating, meets or exceeds new building codes going into effect across the US which require continuous insulation for higher thermal performance standards. Learn more at: https://t.co/LWNDwJcXDh #ContinuousInsulation #HomeBuilding pic.twitter.com/jycn1smuzF
— Innovative Designs, Inc (Stock: $IVDN) (@riccelli_joseph) February 26, 2024
1606 Corp. (OTC: $CBDW): Revolutionizing CBD Customer Service with AI Innovation https://www.redchip.com/media/2997/1606-corp-otc-cbdw-revolutionizing-cbd-customer-service-with-ai-innovation
Silynxcom Ltd $SYNX is an excellent example where fundamentals do more than support bullish sentiment; they expose opportunity. In this case, it's a compelling one. How so? Primarily because despite being better positioned to grow than any time in its history, SYNX shares are trading below its $4.00 January IPO price. From a valuation perspective, that doesn't make much sense. https://www.benzinga.com/pressreleases/24/02/ab37329501/silynxcom-stock-spikes-15-in-february-as-demand-for-its-industry-leading-in-ear-communications-eq
Stock in focus! $CBDW 1606 Corp. Launches an Era of Exceptional Growth of CBDW.ai For E-Commerce
https://cbdw.ai/1606-corp-launches-an-era-of-exceptional-growth-of-cbdw-ai-for-e-commerce/
$AVRW - Dr. Persky will be expanding his support of brand marketing, social media, and advertising campaigns for our patent-pending DNA (Deep Nano Actives) Complex an instant anti-aging skin tightening serum that due to the cutting-edge peptide technology developed exclusively for AVRW allows the ingredients to penetrate to the dermal layers of the skin.
https://finance.yahoo.com/news/avenir-wellness-solutions-issues-2024-140000098.html
$NICH nice loading zone here!!! https://schrts.co/anKewVnB
$TMGI - The company has successfully eliminated an additional $150,000 of its debt this year, accumulating to a total debt reduction of nearly $750,000 in under two years.
$HCTI News: Healthcare Triangle Empowers Healthcare Providers to Harness AI and LLMs for Groundbreaking Outcomes
Company’s latest initiative addresses growing demand for AI analytics to revolutionize patient care
PLEASANTON, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” HCTI” or the “Company”), a leader in transforming healthcare through technology, today unveiled an initiative aimed at enabling healthcare organizations to harness the full potential of their organic data through Artificial Intelligence (AI) and Large Language Models (LLMs).
This initiative is set against the backdrop of a rapidly expanding AI market, with Grand View Research estimating the AI in healthcare market size was $22.45 billion in 2020, and is expected to expand at a compounded annual growth rate (CAGR) of 36.4% from 2024 to 2030. Healthcare Triangle's latest offering is poised to empower healthcare providers with the tools to develop and deploy sophisticated machine learning (ML) models and LLMs, significantly enhancing patient outcomes through personalized and predictive healthcare solutions.
A Strategic Response to a Growing Demand:
The surge in the AI and analytics market highlights an escalating need for sophisticated data-driven solutions in healthcare. Healthcare Triangle's initiative strategically addresses this demand by providing a secure, scalable, and compliant digital platform. This platform facilitates the creation of AI and LLMs customized to meet the specific requirements of the healthcare industry. Through the utilization of organic data, healthcare providers gain access to valuable insights and patterns. These insights enable more precise diagnoses, efficient treatments, and ultimately, elevate the standard of patient care.
Key Features of the Initiative:
Secure and Compliant Data Utilization: Prioritizing data security and privacy, Healthcare Triangle ensures all AI and LLM development is in strict compliance with healthcare regulations, including HITRUST certification and HIPAA compliance. This commitment extends to a secure environment for data transfer, storage, and processing, alongside a comprehensive disaster recovery strategy.
Scalable Infrastructure Ready for the Future: Designed to meet the growing demands of healthcare organizations, the initiative's infrastructure is built for scalability, accommodating increasing data volumes and computational needs without compromising performance. A secure, cloud-hosted lab for LLM development highlights the initiative's readiness for the future, ensuring safety and efficiency in AI and analytics deployment.
Collaborative Ecosystem for Shared Innovation: Facilitating a culture of collaboration, the platform encourages the sharing of insights and methodologies within and between organizations, fostering a community focused on improving patient care and aligning with industry standards.
Customizable AI and LLM Development: Recognizing the diverse needs within healthcare, Healthcare Triangle offers customizable tools and solutions for developing AI and LLM models directly aligned with healthcare outcomes and objectives, ensuring flexibility and cost-effectiveness in platform service management.
A Vision for the Future of Healthcare:
"With the AI and analytics market projected to quadruple by 2024, our initiative represents a timely and necessary leap forward in empowering healthcare providers," stated Anand Kumar, Chief Revenue Officer of Healthcare Triangle. "We are not just advancing technology; we are setting a new standard for patient care, leveraging AI and LLMs to deliver personalized, predictive, and effective healthcare solutions."
As the AI and analytics market continues to grow, Healthcare Triangle's initiative marks a critical step towards realizing a future where healthcare is more personalized, outcomes are improved, and patients receive the care they need, when they need it, setting a new benchmark in healthcare innovation.
About Healthcare Triangle:
Healthcare Triangle, Inc., headquartered in Pleasanton, California, stands at the forefront of healthcare technology, specializing in AI and digital transformation. With a commitment to innovation, collaboration, and excellence, Healthcare Triangle is dedicated to reshaping healthcare delivery for the better. We collaborate with healthcare entities, including hospitals, health systems, payers, and pharma/life sciences organizations, leveraging breakthrough technology and extensive industry expertise to enhance health outcomes through optimized data utilization and cutting-edge information technologies. Holding HITRUST Certification for Cloud and Data Platform (CaDP) – featuring CloudEz™, DataEz™, and readabl.AI – our commitment to the highest standards in data protection and information security is unwavering. Healthcare Triangle serves as a beacon for the adoption of new technologies, data enlightenment, business agility, and swift response to evolving business needs and competitive challenges. Thriving in the highly regulated healthcare and life sciences sectors, we excel in digital transformation encompassing the cloud, security and compliance, identity management, data lifecycle management, healthcare interoperability, and clinical and business performance optimization. For more information, visit www.healthcaretriangle.com
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as “projected,” “expect,” “possibility” and “anticipate.” The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K filed with the SEC on March 28, 2023, subsequent filings and future reports filed with the SEC. All the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
Contacts
Investors:
1-800-617-9550
ir@healthcaretriangle.com
https://www.globenewswire.com/newsroom/ti?nf=OTA0MjA2NSM2MDg0Mjc4IzUwMDEyMTA5OA==
https://ml.globenewswire.com/media/YjI0OWY5YWQtNmMwZC00ZGQwLTg3ODUtNzZhNjcyYjg1NzQxLTUwMDEyMTA5OA==/tiny/Healthcare-Triangle-Inc.png
Source: Healthcare Triangle, Inc
$EVKRF - Tim Fernback, Grid President & CEO comments "Clayton Valley holds the only producing lithium brine system in the United States and also holds amazing potential for lithium clay-hosted deposits.
$MMMW Mass Megawatts Announces Several New Product Lines with Lowest and Competitive Prices as a Source of Generating Revenue
https://www.globenewswire.com/news-release/2024/02/22/2833805/0/en/Mass-Megawatts-Announces-Several-New-Product-Lines-with-Lowest-and-Competitive-Prices-as-a-Source-of-Generating-Revenue.html
$EPAZ - Following a successful collaboration with the US Air Force in SBIR Award Phase 1, ZenaDrone has gained significant traction in acquiring additional contracts valued at $1.2 million
$TMGI - The Marquie Group, Inc. and its affiliate Simply Whim, via its licensor Global Holdings Network, is expected to enter into a coexistence agreement for the WHIM trademark with one of the largest beauty brands in the world.
$CRDV - Mr. Sands is a seasoned veteran in the investment community, having served in positions such as CEO, interim CFO, Director and President of both publicly traded companies and private businesses.
$GDHG News: Golden Heaven Group Holdings Ltd. Announces $6,000,000 Share Repurchase Program
NANPING, China, Feb. 22, 2024 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. (the "Company" or "Golden Heaven") (Nasdaq: GDHG), an amusement park operator in China, announced today that on February 21, 2024, the Company's Board of Directors (the "Board") has authorized a share repurchase program authorizing the Company to repurchase up to US$6,000,000 of the Company's outstanding Class A ordinary shares from time to time during a 24-month period (the "Share Repurchase Program"). The Share Repurchase Program will be facilitated by Dawson James Securities, Inc.
The Board has determined that the Share Repurchase Program is in the best interest of the Company's shareholders based on its analysis and estimation that the current share price is significantly lower than the intrinsic value and that the Share Repurchase Program may improve shareholders' confidence in the Company. The Board will be periodically reviewing the Share Repurchase Program and may authorize adjustments of its terms and size.
In determining the amount of capital to allocate to share repurchases, the Company takes into account, among other things, its historical and expected business performance, cash and liquidity position, as well as global economic and market conditions and the market price of the Company's Class A ordinary shares. The timing, manner, price, and amount of any repurchases under the Share Repurchase Program are determined by the Company in its discretion. Purchases may be affected through open market transactions, privately negotiated transactions, transactions structured through investment banking institutions, or other means. The Company is not obligated to repurchase any specific number of Class A ordinary shares and the program may be modified, suspended, or discontinued at any time.
The Company intends to make all repurchases in compliance with applicable regulatory guidelines and to administer the plan in accordance with applicable laws.
About Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd. manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. With approximately 426,560 square meters of land in the aggregate, these parks are located in geographically diverse markets across the south of China and collectively offer approximately 139 rides and attractions. Due to the geographical locations of the parks and the ease of travel, the parks are easily accessible to an aggregate population of approximately 21 million people. Since September 30, 2023, Mangshi Jinsheng Amusement Park, which is one of the six parks, has been temporarily closed. The parks provide a wide range of exciting and entertaining experiences, including thrilling rides, family-friendly attractions, water attractions, gourmet festivals, circus performances, and high-tech facilities. For more information, please visit the Company's website at https://ir.jsyoule.com/.
Forward-Looking Statements
This press release contains "forward-looking statements". Forward-looking statements reflect our current view about future events. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "could," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "is/are likely to," "propose," "potential," "continue" or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and other filings with the U.S. Securities and Exchange Commission.
For investor and media inquiries, please contact:
Golden Heaven Group Holdings Ltd.
Email: group@jsyoule.com
Ascent Investor Relations LLC
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
View original content:https://www.prnewswire.com/news-releases/golden-heaven-group-holdings-ltd-announces-6-000-000-share-repurchase-program-302068265.html
SOURCE Golden Heaven Group Holdings Ltd.
$CBDW 1606 Corp Discover AI-driven conversational e-commerce for online retailers
$TMGI The Marquie Group Ventures into the Growing Nootropics Beverage Sector
https://finance.yahoo.com/news/marquie-group-ventures-growing-nootropics-150000857.html
$CAUD - a leading provider of digital consumer acquisition solutions.
Followers
|
525
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
45886
|
Created
|
02/21/10
|
Type
|
Free
|
Moderator MaxPowerLove$Ihub | |||
Assistants mick Ask$lapper k124Inv RoadRunner3 |
Welcome!
Sad =( Not Funny! But it's True!
Remember, The OTC Market is like Vegas! Treat trading & investing in every penny stocks like Casino gambling!
Check out some of our picks & results in the past:
Recent Plays:
Le2dynasty: Alerted for CBYI in late March @ the point when the stock was at no bid. A few weeks later the PPS reached .0004s (400% gain)
Le2dynasty: Alerted for GRPS (together with KGRI, CBYI) @ .0001s on May 17th...On May 23rd the PPS touched .0012s (1,200% gain)
Le2dynasty: Alerted for CBYI @ .0001s on May 23rd -- early morning & within a few hours, the PPS reached .0003s with mega trading volume-- (71 mil. total trading vol. with 99% buyin' vol.) (300% gain)
Le2dynasty: Alerted for CBYI @ .0002s on May 24rd -- early morning & immediately, the PPS reached .0004s with mega trading volume -- (more than 100 mil. total trading vol. CBYI was the top in top trading vol. on this day) (100% gain)
Le2dynasty: Alerted for EMLL @ .0002s on July 2nd -- early morning & the PPS reached .0004s with mega trading volume -- (more than 260 mil. total trading vol. EMLL became the top in top trading vol. & top in breakout board on this day) (50% gain)
Le2dynasty: Alerted for HIRU @ .0001s on July 3rd & on July 9, HIRU reached .0006s with mega trading volume (600% gain)
Le2dynasty: Alerted for IMDS @.0005s on July 9 @ the pt. when the total trading vol. is below 80 mil. Within 50 minutes later, the PPS reached .0009s, with more than 245 mil. total trading vol. (80% gain) in less than 1 hr. On July 10th another alert was sent out to remind traders/investors & on July 12th, the PPS reached .0026s..that is more than (500% gain) since July 9 alert.
Le2dynasty: Alerted for NVAE in early moring @ the pt. when the stock was @ no bid. PPS then reached .0003s (200% again) with a mega trading vol. (end the trading day with more than 230 mil total trading vol.). Unfortunately, the the stock dropped back to .0001 at closing.
BurntOrang3: : 400-500% gains off of DRGI after the alert
BurntOrang3: : Over 100% gains after my AUCI alert
**** Attention: Mods, Please don't edit the ibox w/o asking me first, b/c there are some kind of coding problems here ...and the IH Greeks ...Especially IH Greek (Dave) had spent a lot of time fixing this. Thank you Dave and thank all the mods here as well ****
Our Associates:
TheKingPennyStock
Daily 000X Plays
Monster Day Traders
Pinky With Potential!
BOTTOM PLAYS! CHART TECH! RESEARCH! STRATEGIES!
"A Dawgg"
Billionaire Boys Club Member Forum (BBCMF)
THE WALL STREET CLUB
$THE WAVE
THE BLUE EXCHANGE
ALERTS, CHARTS, & HOT STOCKS
Momentum Players
Momentum Runners
MOMO'S BREAKOUT BOARD
STOCKGOODIES PLAYS OF THE WEEK
Welcome To The Zoo
~~~TEFFY''S~~~HOT~~~PROFILED~~~PICKS~~~
Another Winning Trade
CASH COW
EZ Traders Forum
NO BRAINERS
StocksDiva Bio Bin
Pinto Beans and Money Making Stock Picks
PINKSHEET Breakout Board!!!
Picks For Every Play
Penny Stock Millionaire
The Van Scan
UNDERVALUED PENNY STOCKS
The Penny Stock Grow Room
Wowza board
Disclaimer: We are not investment advisors. We recommend investors to do their own due diligence. Never invest in any stock unless you can afford to lose your entire investment. Opinions expressed on this board are only opinions.
PER IHUB MGMT |
02-07-2021
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION
AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
Posts Today
|
0
|
Posts (Total)
|
45886
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |